Krane Funds Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-121
| Closed | -$14K | – | 375 |
|
|
2021
Q1 | $14K | Hold |
121
| – | – | ﹤0.01% | 284 |
|
|
2020
Q4 | $14K | Buy |
121
+35
| +41% | +$4.05K | ﹤0.01% | 288 |
|
|
2020
Q3 | $10K | Buy |
86
+43
| +100% | +$5K | ﹤0.01% | 226 |
|
|
2020
Q2 | $4K | Sell |
43
-19
| -31% | -$1.77K | ﹤0.01% | 241 |
|
|
2020
Q1 | $7K | Hold |
62
| – | – | ﹤0.01% | 219 |
|
|
2019
Q4 | $7K | Sell |
62
-32
| -34% | -$3.61K | ﹤0.01% | 220 |
|
|
2019
Q3 | $11K | Hold |
94
| – | – | ﹤0.01% | 213 |
|
|
2019
Q2 | $9K | Sell |
94
-412
| -81% | -$39.4K | ﹤0.01% | 206 |
|
|
2019
Q1 | $46.2K | Buy |
506
+33
| +7% | +$3.01K | ﹤0.01% | 77 |
|
|
2018
Q4 | $36 | Buy |
473
+329
| +228% | +$25 | ﹤0.01% | 78 |
|
|
2018
Q3 | $13K | Buy |
+144
| New | +$13K | ﹤0.01% | 77 |
|